Literature DB >> 17561806

Translocator protein (18 kDa) ligand PK 11195 induces transient mitochondrial Ca2+ release leading to transepithelial Cl- secretion in HT-29 human colon cancer cells.

Mariano A Ostuni1, Robert Ducroc, Gabriel Péranzi, Marie-Christine Tonon, Vassilios Papadopoulos, Jean-Jacques Lacapere.   

Abstract

BACKGROUND INFORMATION: TSPO (translocator protein), known previously as PBR (peripheral-type benzodiazepine receptor), is a 18 kDa protein expressed in the mitochondrial membrane of a variety of tissues. TSPO has been reported to be over-expressed in human colorectal tumours and cancer cell lines, but its function is not well characterized.
RESULTS: We investigated the expression and function of TSPO in the human colon cancer cells HT-29. Immunohistochemical studies revealed that TSPO is localized in mitochondria, and its endogenous ligand, the polypeptide diazepam-binding inhibitor, in the cytosol. Radioligand binding studies using the specific high-affinity drug ligand [(3)H]PK 11195 and membrane fraction demonstrated saturable binding, with K(d) and B(max) values of 13.5+/-1.5 nM and 10.1+/-1.0 pmol/mg respectively. PK 11195 induced a rapid and transient dose-dependent rise in intracellular [Ca(2+)], which was unaffected by extracellular Ca(2+), but was blocked by the PTP (permeability transition pore) inhibitor, cyclosporin A, and by the TSPO partial agonist, flunitrazepam. Using HT-29 clone 19A cell line, which forms cell monolayers, we demonstrated that TSPO ligand stimulated a Ca(2+)-dependent transepithelial Cl(-) secretion. This secretion was inhibited: (i) after removal of extracellular Cl(-); (ii) by apical addition of the Cl(-) channel blocker NPPB [5-nitro-2-(3-phenylpropylamino)-benzoate]; and (iii) by basolateral addition of the Na(+)-K(+)-2Cl(-) co-transporter inhibitor bumetanide. Furthermore, the intracellular Ca(2+) chelator BAPTA/AM [bis-(o-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid tetrakis(acetoxymethyl ester)] and cyclosporin A abolished the rise in PK 11195-induced Cl(-) secretion.
CONCLUSIONS: These findings indicate that TSPO is located in mitochondrial membranes of HT-29 and reveal that its activation induces a rise in cytosolic Ca(2+), leading to the stimulation of Cl(-) secretion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561806     DOI: 10.1042/BC20070048

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  13 in total

1.  Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state.

Authors:  Judy Choi; Masataka Ifuku; Mami Noda; Tomás R Guilarte
Journal:  Glia       Date:  2011-02       Impact factor: 7.452

2.  Overexpression of translocator protein in inflammatory bowel disease: potential diagnostic and treatment value.

Authors:  Mariano A Ostuni; Leeyah Issop; Gabriel Péranzi; Francine Walker; Magali Fasseu; Carole Elbim; Vassilios Papadopoulos; Jean-Jacques Lacapere
Journal:  Inflamm Bowel Dis       Date:  2010-09       Impact factor: 5.325

3.  [18F]FEPPA: Improved Automated Radiosynthesis, Binding Affinity, and Preliminary in Vitro Evaluation in Colorectal Cancer.

Authors:  Neydher Berroterán-Infante; Theresa Balber; Petra Fürlinger; Michael Bergmann; Rupert Lanzenberger; Marcus Hacker; Markus Mitterhauser; Wolfgang Wadsak
Journal:  ACS Med Chem Lett       Date:  2018-02-21       Impact factor: 4.345

Review 4.  Targeting cancer cell mitochondria as a therapeutic approach.

Authors:  Shijun Wen; Daqian Zhu; Peng Huang
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

5.  Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription.

Authors:  Hui-Jie Wang; Jinjiang Fan; Vassilios Papadopoulos
Journal:  Cell Tissue Res       Date:  2012-08-07       Impact factor: 5.249

Review 6.  TSPO protein binding partners in bacteria, animals, and plants.

Authors:  Carrie Hiser; Beronda L Montgomery; Shelagh Ferguson-Miller
Journal:  J Bioenerg Biomembr       Date:  2021-06-30       Impact factor: 2.945

7.  Translocator Protein-Mediated Stabilization of Mitochondrial Architecture during Inflammation Stress in Colonic Cells.

Authors:  Leeyah Issop; Mariano A Ostuni; Sunghoon Lee; Mireille Laforge; Gabriel Péranzi; Pierre Rustin; Jean-François Benoist; Jérome Estaquier; Vassilios Papadopoulos; Jean-Jacques Lacapère
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

8.  TSPO ligands stimulate ZnPPIX transport and ROS accumulation leading to the inhibition of P. falciparum growth in human blood.

Authors:  I Marginedas-Freixa; C Hattab; G Bouyer; F Halle; A Chene; S D Lefevre; M Cambot; A Cueff; M Schmitt; B Gamain; J J Lacapere; S Egee; F Bihel; C Le Van Kim; M A Ostuni
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379

9.  Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195.

Authors:  Michelangelo Campanella; Gyorgy Szabadkai; Rosario Rizzuto
Journal:  Biochem Pharmacol       Date:  2008-10-04       Impact factor: 5.858

10.  Cardiac-specific Conditional Knockout of the 18-kDa Mitochondrial Translocator Protein Protects from Pressure Overload Induced Heart Failure.

Authors:  Phung N Thai; Daniel J Daugherty; Bert J Frederich; Xiyuan Lu; Wenbin Deng; Donald M Bers; Elena N Dedkova; Saul Schaefer
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.